3-(4'-fluorophenyl)pentan-3-ol | 76481-34-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4'-fluorophenyl)pentan-3-ol
• 英文别名: 3-(4-Fluoro-phenyl)-pentan-3-ol；3-(4-fluorophenyl)pentan-3-ol
• CAS: 76481-34-0
• 化学式: C₁₁H₁₅FO
• 分子量: 182.238
• InChiKey: KPTARFXLMVRLBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(4'-fluorophenyl)pentan-3-ol 在 三氟化硼乙醚 、 水 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 以90%的产率得到1-fluoro-4-(pent-2-en-3-yl)benzene
  参考文献：
  名称：

  [EN] VITAMIN D RECEPTOR MODULATORS
  [FR] MODULATEURS DU RECEPTEUR DE LA VITAMINE D

  摘要：

  公开号：

  WO2005051940A3
• 作为产物：
  描述：

  1,4-二氟苯 在 萘 、 lithium 作用下， 以 四氢呋喃 为溶剂， 反应 3.58h， 生成 3-(4'-fluorophenyl)pentan-3-ol
  参考文献：
  名称：

  Arene-Catalysed Lithiation of Fluoroarenes

  摘要：

  The reaction of different fluoroarenes 1 with lithium and a catalytic amount (7%) of naphthalene in THF at -30 degrees C affords the corresponding aryllithium intermediates which, by reaction with several electrophiles at temperatures ranging between -30 and 0 degrees C, lead to the expected products 2, after hydrolysis. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00013-2

文献信息

• Triphosgene and DMAP as Mild Reagents for Chemoselective Dehydration of Tertiary Alcohols
  作者：Moshood O. Ganiu、Alexander H. Cleveland、Jarrod L. Paul、Rendy Kartika

  DOI：10.1021/acs.orglett.9b01959

  日期：2019.7.19

  The utility of triphosgene and DMAP as mild reagents for chemoselective dehydration of tertiary alcohols is reported. Performed in dichloromethane at room temperature, this reaction is readily tolerated by a broad scope of substrates, yielding alkenes preferentially with the (E)-geometry. While formation of the Hofmann products is generally favored, a dramatic change in alkene selectivity toward the

  据报道，三光气和DMAP作为温和试剂用于叔醇的化学选择性脱水。该反应在室温下在二氯甲烷中进行，很容易被宽范围的底物所耐受，优先以（E）-几何结构产生烯烃。尽管通常优选霍夫曼产物的形成，但是当反应在二氯乙烷中在回流下进行时，观察到烯烃对Zaitzev产物的选择性的急剧变化。
• [EN] INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS<br/>[FR] MODULATEURS A BASE DE DERIVES INDOLIQUES DES RECEPTEURS NUCLEAIRES DES HORMONES STEROIDES
  申请人：LILLY CO ELI

  公开号：WO2004067529A1

  公开（公告）日：2004-08-12

  The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.

  本发明提供了一种I式化合物或其药学上可接受的盐，包括I式化合物的有效量与适当载体、稀释剂或赋形剂组合而成的药物组合物，以及治疗生理紊乱的方法，特别是充血性心脏病，包括向患者施用I式化合物的有效量。
• Synthesis and Pharmacological Evaluation of 1-Alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide Derivatives as Novel Antihypertensive Agents
  作者：Susumu Watanuki、Keisuke Matsuura、Yuichi Tomura、Minoru Okada、Toshio Okazaki、Mitsuaki Ohta、Shin-ichi Tsukamoto

  DOI：10.1248/cpb.59.1376

  日期：——

  We synthesized and evaluated inhibitory activity against T-type Ca2+ channels for a series of 1-alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide derivatives. Structure–activity relationship studies have revealed that the isopropyl substituent at the benzylic position plays an important role in exerting potent inhibitory activity, and the absolute configuration of the benzylic position was found to be opposite that of mibefradil, which was first launched as a new class of T-type Ca2+ channel blocker. Oral administration of N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]-1-[2-(3-methoxyphenyl)ethyl]piperidine-4-carboxamide (17f) lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, an adverse effect often caused by traditional L-type Ca2+ channel blockers.

  我们合成并评估了一系列1-烷基-N-[(1R)-1-(4-氟苯基)-2-甲基丙基]哌啶-4-羧酰胺衍生物对T型钙通道的抑制活性。结构-活性关系研究表明，苄位异丙基取代基在发挥强效抑制活性中起着重要作用，并且苄位的绝对构型与作为新型T型钙通道阻滞剂首次上市的米贝地尔相反。N-[(1R)-1-(4-氟苯基)-2-甲基丙基]-1-[2-(3-甲氧基苯基)乙基]哌啶-4-羧酰胺（17f）的口服给药能降低自发性高血压大鼠的血压，而不会引起反射性心动过速，这是传统L型钙通道阻滞剂常见的不良反应。
• Carbocation NMR isotope shifts analogous to inverse γ-deuterium isotope effects
  作者：David A. Forsyth、James S. Puckace、Frances E. Shawcross

  DOI：10.1016/s0040-4039(00)84851-0

  日期：1986.1

  Long-range NMR isotope shifts due to γ-deuteration in carbocations are upfield, in contrast to β-deuteration effects. Such behavior is analogous to kinetic and equilibrium isotope effects in carbocation-forming reactions.

  与β-氘代作用相反，碳阳离子中由于γ-氘代引起的远距离NMR同位素位移是高场的。这种行为类似于碳正离子形成反应中的动力学和平衡同位素效应。
• Indole-derivative modulators of steroid hormone nuclear receptors
  申请人：Bell Gregory Michael

  公开号：US20060235222A1

  公开（公告）日：2006-10-19

  The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.

  本发明提供了一种I式化合物或其药学上可接受的盐，包括与适当的载体、稀释剂或赋形剂组合的有效量的I式化合物的药物组成物，以及治疗生理障碍，特别是充血性心脏病的方法，包括向患者施用有效量的I式化合物。